The cytoplasmatic pattern recognition receptor, NOD2 (nucleotide-binding oligomerization domain 2), belongs to the innate immune system and is among others responsible for the recognition of single-stranded RNA. With Coxsackievirus B3 (CVB3) being a singlestranded RNA virus, and the recent evidence that the NOD2 target, NLRP3 (NOD-like receptor family, pyrin domain containing 3) is of importance in the pathogenesis of CVB3-induced myocarditis, we aimed to unravel the role of NOD2 in CVB3-induced myocarditis.
V iral myocarditis is a cardiac disorder characterized by cardiac inflammation because of a viral infection and may progress to dilated cardiomyopathy and congestive heart failure. 1 Coxsackievirus group B type 3 (CVB3) belongs to the most relevant virus types in viral myocarditis. Despite extensive study, the pathogenesis of CVB3-induced myocarditis is still under investigation, and therapy options are limited.
2 CVB3 is known to cause direct cardiomyocyte injury. 3 However, there is accumulating evidence showing that particularly the virus-induced uncontrolled, long-term inflammatory reaction exerts detrimental effects in viral myocarditis, 3, 4 having a severe impact on cardiac events, transplantation rate, and survival. 5 Therefore, further understanding of the CVB3-induced inflammatory response is required, enabling to find efficient therapeutical options counteracting the virus-induced inflammatory response.
The innate immune response is an immediate counterattack after entry of the virus. 6 This defense mechanism is achieved in part through immune surveillance by patternrecognition receptors, including Toll-like receptors and the intracellular NOD (nucleotide-binding oligomerization domain)-like receptors (NLRs), 7 recognizing pathogen-or damage-associated molecular patterns. NOD2 is a wellcharacterized member of the NLR family. It recognizes the peptidoglycan muramyl dipeptide, which is found in both Gram-negative and Gram-positive bacteria, and most importantly, also single-stranded RNA viruses. 8 NOD2 leads among others to nuclear factor-κB (NF-κB) activation, which in turn licenses NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome activation by regulating NLRP3 expression. 9 The NLRP3 inflammasome is an intracellular multiprotein complex existing of NLRP3, the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD), and caspase-1 and responsible for the processing of the proinflammatory cytokines pro-IL-1β (interleukin-1β) and pro-IL-18 into their mature secreted forms. 9 Its relevance has recently been demonstrated in CVB3 myocarditis. 10 With CVB3 being a single-stranded RNA virus, and the recent evidence that the NOD2 target NLRP3 is of importance in the pathogenesis of CVB3-induced myocarditis, 10, 11 we wanted to unravel the role of NOD2 in CVB3-induced myocarditis and to understand underlying mechanisms.
METHODS Patients
The study group comprised 39 patients with an endomyocardial biopsy (EMB)-proven CVB3-negative acute myocarditis (AMC; n=13), CVB3-negative chronic inflammatory dilative cardiomyopathy (DCMi; n=5), a chronic dilative cardiomyopathy without evidence of cardiac inflammation (DCM; n=8), and 13 CVB3-positive patients (AMC; n=6; DCMi; n=7). In addition, 6 patients who eliminated cardiac CVB3 over time, proven by follow-up EMBs (n=6), were studied in a subgroup. Twelve patients served as controls where a cardiac cause for exercise limitation and chest complaints could be excluded after several investigations, including regular findings in their EMBs. Coronary artery disease was angiographically excluded in all patients. All diagnostic procedures and evaluation were obtained by using standardized protocols. 12 All patients provided written consent for the EMBs. Detailed information of the clinical definition of disease entities and information about EMB analysis for diagnosis is given in the expanded methods in the Data Supplement.
Mice and Study Design
NOD2 knockdown ( −/− ) mice and wild-type (WT; C57BL/6) mice were provided by the Department of Microbiology and Hygiene, Charité-Universitätsmedizin Berlin (Berlin, Germany). 13 Male NOD2 −/− mice were generated on a genetic background of C57BL/6. The experimental groups included control WT, NOD2 −/− , WT CVB3, and NOD2 −/− CVB3 (n=6-9/ group). Six-week-old WT mice (WT CVB3) and NOD2 −/− mice (NOD2 −/− CVB3) were randomly divided and infected with 5×10 5 plaque-forming units of CVB3 (Nancy strain) via intraperitoneal injection. An identical volume of saline (0.2 mL) was injected into control animals instead of CVB3. Seven days post-infection, mice were hemodynamically characterized and subsequently euthanized. Left ventricles, blood, and spleens were isolated for further analysis. The experiment
WHAT IS NEW?
• The present study demonstrates the relevance of NOD2 (nucleotide-binding oligomerization domain 2), a cytoplasmatic pattern recognition receptor, in the pathogenesis of Coxsackievirus B3 (CVB3)-induced myocarditis.
• CVB3 infection elevates cardiac NOD2 expression.
• NOD2 knockdown ( −/− ) protects CVB3-infected myocarditis mice from the detrimental effects of CVB3: less cardiac inflammation, fibrosis, apoptosis, and viral load and an improved left ventricular function compared with wild-type CVB3 mice.
• NOD2 −/− is associated with a decrease in CVB3-induced NLRP3 (NOD-like receptor family, pyrin domain containing 3) expression and activity.
• Cardiac NOD2 expression drops in CVB3-positive patients who clear the virus over time.
WHAT ARE THE CLINICAL IMPLICATIONS?
• This study demonstrates that NOD2 is a major mediator in the pathogenesis of CVB3-induced myocarditis and opens up new avenues to explore.
• The analysis of NOD2 in endomyocardial biopsies could be useful as an additional differential diagnostic marker for CVB3-induced myocarditis under clinical conditions. • The NOD2 signaling pathway could serve as a new important interventional target to treat CVB3-induced myocarditis.
was approved by the local ethics committee (Landesamt für Gesundheit und Soziales, Berlin, G0084/12) and is conform to the European legislation (Directive 2010/63/EU).
Hemodynamic Measurements and Surgical Procedures
Seven days after infection, mice were anesthetized (0.8-1.2 g/kg urethane and 0.05 mg/kg buprenorphine intraperitoneally), intubated, and mechanically ventilated. The hemodynamical function of the heart was measured by a 1.2 French microconductance pressure catheter (Scisense Inc., Ontario, Canada) in closed-chest animals as described previously. 3 After hemodynamic measurements, mice were euthanized. The hearts, spleens, and sera were removed, snap frozen in liquid nitrogen, and stored at −80°C for molecular and immunohistochemical examinations.
RNA Isolation, cDNA Synthesis, and Gene Expression Analysis
For total RNA isolation from murine tissue, EMBs, and in vitro experiments, the TRIzol (Life Technologies GmbH, Darmstadt, Germany) method was used, followed by cDNA synthesis with the High Capacity Kit (Life Technologies GmbH). Because of limited amounts of EMB cDNA, a preamplification technique was applied preceding gene expression analysis, as described before.
14 To assess the relative mRNA expression of the target genes in EMBs, murine left ventricles (LVs), spleens, and HL-1 cardiomyocytes, real-time polymerase chain reaction was performed on a Viia7 system (Life Technologies GmbH) or on a QuantStudio 6 Flex (Life Technologies, Darmstadt, Deutschland). For gene expression assays, please refer to the expanded methods in the Data Supplement.
Immunohistochemistry
Cardiac Monocyte Chemoattractant Protein-1 (MCP-1), CAR (Coxsackievirus and adenovirus receptor) and ASC expression, immune infiltrates, and fibrosis were detected on Tissue-Tek OCT (Sakura, Zoeterwoude, NL)-embedded 5-μm-thick tissue slides. For detailed information, please refer to the expanded methods in the Data Supplement.
Western Blot
LV NLRP3 and GAPDH protein expression was determined via Western Blot after loading of 40 μg of protein into 10% SDSpolyacrylamide gels. For detailed information, please refer to the expanded methods in the Data Supplement.
Plaque Assay
The amount of infectious CVB3 in LVs from NOD2 −/− CVB3 and WT CVB3 mice and in supernatant of CVB3 NOD2 siRNA and CVB3 scr siRNA HL-1 cells was determined on a monolayer of HeLa cells by plaque assay. For detailed information, please refer to the expanded methods in the Data Supplement. 
Determination of Cardiac Apoptosis

IL-1β ELISA
Sera were stored at −80°C. To detect IL-1β concentrations, sera were thawn on ice. Subsequently, 50 μL of undiluted sera samples were analyzed by using the instant ELISA assay from eBiosciences according to the manufacturer's protocol (eBiosciences, Frankfurt am Main, Germany).
Cell Culture Experiments
The murine cardiomyocyte cell line HL-1 was cultured in full Claycomb medium (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) supplemented with 10% FBS (Biochrom, Berlin, Germany), 1% penicillin/streptomycin (Life Technologies GmbH), 0.1 mmol/L norepinephrine (Sigma-Aldrich Chemie GmbH), and 2 mmol/L l-glutamine (Biochrom, Berlin, Germany).
NOD2 siRNA Transfection and Coxsackievirus B3 Infection
For the transfection and CVB3 (Nancy strain, ATCC VR-30) experiments, HL-1 cells were plated into gelatin/fibronectin (Sigma-Aldrich Chemie GmbH) precoated 6-or 96-well plates at a density of 200 000 or 7500 cells/well, respectively. Twenty-four hours later, cells were transfected at a final concentration of 5 nmol/L for NOD2 and scr siRNA (Life Technologies GmbH). CVB3 infection occurred 24 hours after transfection at a multiplication of infection of 2 or 4, depending on the experimental setting. For detailed transfection and infection procedures, please refer to the expanded methods in the Data Supplement.
NOD2 siRNA Transfection and Tumor Necrosis Factor-α Stimulation
Tumor necrosis factor-α (TNF-α; 10 ng/mL; BD Biosciences) stimulation of HL-1 cells in full Claycomb medium occurred 24 hours after transfection with 5 nmol/L of NOD2 and scr siRNA (Life Technologies). Twenty-four hours later, cells were subsequently used for ASC and IL-1β flow cytometry.
Caspase 3/7 Activity Assay
The caspase-Glo 3/7 assay kit was applied on siRNAtransfected HL-1 cells, 24 hours post-CVB3 infection. Overall, the caspase 3/7 activity was estimated according to the manufacturer's protocol (Promega, Mannheim, Germany) and measured with a luminometer (Berthold Mithras LB 940 reader, Berthold Technologies, Bad Wildbad, Germany). For detailed information on normalization of caspase activity to cell amount, please refer to the Data Supplement.
Intracellular ASC, Pro-IL-1β, IL-1β, and Caspase-1 Activity Flow Cytometry
Phycoerythrin-conjugated mouse anti-ASC (TMS-1; BioLegend, Fell, Germany), phycoerythrin-conjugated mouse IL-1β proform (eBioscience, San Diego, CA), PerCP-conjugated mouse anti-IL-1β/IL-1F2 (R&D Systems, Wiesbaden-Nordenstadt, Germany) antibodies, and a FAM-YVAD caspase-1 inhibitor (Immunochemistry technologies/Biomol, Hamburg, Germany) were used for the detection of intracellular ASC, pro-IL-1β, IL-1β, and caspase-1 activity. Sample analysis was performed on a MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany). Reanalysis of flow cytometry data was performed using FlowJo software version 8. 
Statistical Analyses
Statistical analysis of experimental in vitro, in vivo, and EMB data was performed using GraphPad Prism 6.0 software (GraphPad Software, La Jolla, CA 
RESULTS
Impact of Coxsackievirus B3 Infection on NOD2 Regulation
EMB NOD2 mRNA expression was 2.1-fold (P<0.005) higher in CVB3-positive patients compared with control patients and not induced in CVB3-negative AMC patients nor in CVB3-negative DCMi or chronic dilative cardiomyopathy patients without evidence of cardiac inflammation (DCM) versus controls ( Figure 1A ; patient characteristics Table I in the Data Supplement). Furthermore, NOD2 mRNA expression was 2.2-fold (P<0.0005) and 2.1-fold (P<0.005) higher in EMB of CVB3-positive patients compared with virus-negative and parvovirus B19-or human herpesvirus 6-positive patients, respectively ( Figure 1B) . Analysis of NOD2 mRNA expression in EMB of CVB3-positive patients who eliminated CVB3 and improved cardiac function over time revealed a 2.5-fold (P<0.05) drop in NOD2 mRNA expression between time point 1 and 2 ( Figure 1C ). This was paralleled with a 2.2-fold (P<0.05) and 4.5-fold (P=0.0592) decrease in mRNA expression of the NOD2 downstream targets NLRP3 and IL-1β over time, respectively ( Figure 1C ).
CVB3 infection in C57BL/6 mice induced LV NOD2 mRNA expression by 2.2-fold (P<0.0005) compared with uninfected control mice ( Figure 1D ). Based on these clinical and experimental data, we further explored the role of NOD2 in experimental CVB3-induced myocarditis in vivo and in vitro models via investigating cardiac function, inflammation, fibrosis, viral uptake and load, and apoptosis.
Impact of NOD2 −/− on Hemodynamic Function in Coxsackievirus B3-Infected Mice
Global heart function was improved in NOD2 −/− CVB3 mice compared with WT CVB3 mice, as shown by a 16% (P<0.001), 43% (P<0.05), and 59% (P<0.05) enhancement in ejection fraction, cardiac output, and stroke work compared with WT CVB3 mice ( 
Impact of NOD2 −/− on Coxsackievirus B3-Induced Cardiac Inflammation
To further assess the role of NOD2 on CVB3-induced cardiac inflammation, mediators of cardiac inflammation, including the expression of the chemokine MCP-1, which plays a crucial role in the inflammation process of CVB3-induced myocarditis by attracting immune cells into the heart, 15 the presence of cardiac infiltrates, and LV cytokine expression were analyzed. 
Impact of NOD2 −/− on Myocardial Fibrosis in Coxsackievirus B3-Infected Mice
Collagen I and III mRNA expression was 1.7-fold (P<0.05) and 1.8-fold (P<0.05) lower in NOD2 −/− CVB3 mice compared with WT CVB3 mice ( Figure 3A and 3B) , which was translated in a 2.8-fold (P<0.0005) lower collagen I/III protein ratio in NOD2 −/− CVB3 versus WT CVB3 mice, as demonstrated by immunohistochemistry ( Figure 3D ). Further evaluation of the expression of the profibrotic factor transforming growth factor-β (TGF-β), which leads to the transformation of fibroblasts into myofibroblasts, and of the myofibroblast marker alpha-smooth muscle actin, revealed 1.5-fold (P<0.05) lower TGF-β mRNA levels and 1.6-fold (P<0.05) less abundant alpha-smooth muscle actin protein expression in NOD2 −/− CVB3 versus WT CVB3 mice, respectively ( Figure 3C and 3E) .
Impact of NOD2 −/− on Viral Load, CAR, and Apoptosis in Experimental Coxsackievirus B3 Models
CVB3 RNA copy number and viral titers were 12.5-fold (P<0.05) and 36-fold (P<0.05; Figure 4A) In line with these in vivo findings, CVB3 copy number 14 hours postinfection and viral progeny release 24 hours post-infection were 1.4-fold (P<0.0005) and 1.6-fold (P<0.0005; Figure 4B ) lower in NOD2 siRNA HL-1 cells compared with CVB3-infected scr siRNA HL-1 cells, respectively (copy number in CVB3 NOD2 siRNA: 1.1×10 7 ±1.1×10 6 [n=5] versus CVB3 scr siRNA 1.5×10 7 ±6.3×10 5 [n=6]). Given the importance of the CAR for the infectivity of cells by CVB3, 16, 17 we next evaluated whether the lower CVB3 copy number in NOD2 −/− CVB3 versus CVB3 mice and CVB3-infected NOD2 siRNA versus scr siRNA HL-1 cells could be because of differences in CAR expression. NOD2 −/− and NOD2 −/− CVB3 mice exhibited both 1.7-fold (P<0.05) lower CAR protein levels compared with respective WT and CVB3 mice ( Figure 4C and 4D) . Also in vitro, knockdown of NOD2 resulted in a 1.8-fold (P<0.005) reduction of CAR mRNA expression in both NOD2 siRNA cells versus respective uninfected and CVB3-infected scr siRNA cells. (Figure 4E ).
Because cardiomyocyte apoptosis is an important trigger for CVB3 viral progeny release, 3 we next analyzed the impact of NOD2 −/− on cardiac apoptosis. CVB3 infection of WT mice resulted in a 11-fold (P<0.005) increase of TUNEL + cells compared with the WT group ( Figure 4F and 4G) , whereas NOD2 −/− CVB3 mice displayed 19-fold (P<0.005) lower levels of TUNEL + cells compared with WT CVB3 mice ( Figure 4F and 4G) . In vitro, caspase 3/7 activity was 1.2-fold (P<0.05) lower in the NOD2 siRNA CVB3-infected versus scr siRNA CVB3 cells ( Figure 4H ).
Impact of NOD2 −/− on the NLRP3 Inflammasome
Because NLRP3 is a downstream target of NOD2, which relevance has recently been shown in CVB3-induced myocarditis, 10 serving as a platform for caspase-1 activation and caspase-1-dependent proteolytic maturation and secretion of IL-1β, 9 we next evaluated the impact of NOD2 −/− on NLRP3, ASC, IL-1β expression or caspase 1 activity in CVB3-infected NOD2 −/− mice and in vitro. CVB3-infected mice displayed 1.8-fold (P<0.05), 17-fold (P<0.01), and 6.2-fold (P<0.0005) higher LV NLRP3 and ASC protein levels and IL-1β mRNA expression, respectively, and 2.0-fold (P<0.05) higher IL-1β serum levels compared with uninfected WT mice ( Figure 5A through 5E), whereas LV NLRP3 and ASC protein levels and IL-1β mRNA expression were 1.8-fold (P<0.0005), 4.4-fold (P<0.005), and 3.0-fold (P<0.0005) lower in NOD2 −/− CVB3 versus WT CVB3 mice, respectively ( Figure 5A through 5D). The lower IL-1β LV mRNA expression was paralleled by a slight but not significant (P=0.0512) decrease of IL-1β serum levels in NOD2 −/− CVB3 compared with WT CVB3 mice ( Figure 5E ). Also in vitro, where 4 hours post-infection, NOD2 mRNA expression was not significantly induced in scr siRNA CVB3 compared with uninfected scr siRNA cells (Figure 5F ), NLRP3 mRNA and ASC protein expression was 1.7-fold (P<0.05) and 1.5-fold (P<0.0005) higher in CVB3-infected scr siRNA versus noninfected scr siRNA HL-1 cells, respectively. (Figure 5G and 5H) . This was associated with a 1.7-fold (P<0.0005) increase in caspase 1 activity in CVB3-infected scr siRNA cells compared with scr siRNA cells, which was reflected in a 1.5-fold (P<0.0005) increase of mature IL-1β ( Figure 5I and 5K) . In contrast, CVB3-infected NOD2 siRNA HL-1 displayed 1.9-fold (P<0.05) and 1.4-fold (P<0.005) lower mRNA expression of NLRP3 and lower protein levels of ASC compared with infected scr siRNA cells, respectively ( Figure 5G and  5H) . Interestingly, NOD2 siRNA CVB3 cells exhibited 1.3-fold (P<0.05) lower caspase-1 activity and 1.3-fold (P<0.0005) lower IL-1β protein levels versus scr siRNA CVB3 cells ( Figure 5I and 5K) , whereby pro-IL-1β protein levels were unaltered among the 4 groups ( Figure 5J ).
To investigate whether the NOD2-mediated impact on downstream NLRP3 also occurs independently of CVB3, we evaluated the impact of TNF-α stimulation on ASC and IL-1β expression in scr siRNA and NOD2 siRNA in the Data Supplement). These data indicate that the TNF-α-induced IL-1β expression occurred in the absence of NLRP3 activation, following NOD2-NF-κB signaling, 9 and point out that the NOD2-mediated activation of NLRP3 is CVB3 dependent.
DISCUSSION
In the present study, we demonstrate the relevance of NOD2 in viral uptake and its link to the NLRP3 inflammasome in cardiac CVB3 myocarditis. This follows from the finding that NOD2 −/− mice are rescued from the detrimental CVB3-mediated effects as shown by a reduced cardiac inflammation (less cardiac infiltrates, suppression of proinflammatory cytokines), cardiac fibrosis, lower CAR expression and CVB3 copy number, apoptosis, and an improved LV function in NOD2 −/− CVB3 compared with WT CVB3 mice. In line with our in vivo findings, NOD2 −/− in vitro resulted in an impaired CVB3-induced inflammatory response, lower CAR expression and CVB3 copy number, and decreased apoptosis. Both in vivo and in vitro, NOD2 −/− was associated with a decrease in CVB3-induced NLRP3 expression and activity. The clinical relevance of NOD2 follows from our clinical observation that CVB3-positive patients express more cardiac NOD2 than CVB3-negative AMC, DCMi, DCM, or control patients and that NOD2 drops in CVB3-positive patients who clear the virus over time.
CVB3 infection induces cardiac damage via a direct cardiomyocyte cytopathic effect and an increased inflammatory response. Accumulating evidence indicates that particularly this inflammatory arm causes the detrimental effects in CVB3-induced myocarditis. 4 In this regard, the relevance of the inflammasome NLRP3 has recently been demonstrated in (CVB3) myocarditis, experimentally 10 as well as clinically.
11
The findings that (1) the intracellular pattern recognition receptor NOD2 recognizes single-stranded RNA viruses, (2) NLRP3 is a downstream target of NOD2, 9 which importance has recently been recognized in myocarditis, 10, 11 and our observations that (3) NOD2 expression is increased in EMBs of CVB3 + patients versus control patients and (4) in LVs of CVB3-infected versus control mice motivated us to further unravel the role of NOD2 in CVB3-induced myocarditis. NOD2 −/− CVB3 mice exhibited a minor inflammatory response compared with WT CVB3 mice as evidenced by a lower protein expression of the chemokine MCP-1 15 and a concomitant decreased cardiac presence of macrophages (CD68 + ) and T cells (CD3 + and CD4 + ). These findings are confirmed by Li et al, 18 who demonstrated that NOD2 ablation leads to reduced LV MCP-1 expression and diminished cardiac macrophages (CD68 + ) infiltration in an experimental mouse myocardial infarction model and are further corroborated by the finding that the downstream NOD2 target NF-κB 9 regulates the transcription of MCP-1. 19 In parallel, LV mRNA levels of TNF-α, IL-6, and IL-1β were less in NOD2 −/− CVB3 compared with WT CVB3 mice. Consistent with the findings in NOD2
−/− mice, NOD2 −/− in HL-1 cells suppressed the CVB3-induced TNF-α, IL-6, and IL-1β mRNA expression. IL-1β signaling is known to be involved in the CVB3-mediated induction of proinflammatory cytokines, 10, 20 by which IL-1β release depends on the inflammasome. We provide evidence that NOD2 −/− decreases the CVB3-induced LV protein expression of the NLRP3 inflammasome components NLRP3 and ASC and lowers IL-1β serum levels. The link between NOD2 and NRLP3 was further assessed in vitro, where NOD2 silencing resulted in a decrease of CVB3-induced NLRP3 mRNA and ASC protein expression, caspase 1 activity, and processing of pro-IL1β to IL-1β.
In parallel to the less pronounced inflammatory response in NOD2 −/− CVB3 compared with WT CVB3 mice, NOD2 −/− was further associated with an antiviral effect as indicated by a lower CVB3 copy number and titer in NOD2 −/− CVB3 compared with WT CVB3 mice, as well as in NOD2 siRNA CVB3 compared with scr siR-NA CVB3 cells and respective supernatants. In vivo and in vitro evaluation of the expression of CAR, relevant for CVB3 uptake, 16, 17 indicated that NOD2 −/− led to a decrease in CAR expression. CAR expression is induced by inflammatory mediators 21 and the MyD88-NF-κB pathway, 22 suggesting that a decrease in NOD2-NF-κB signaling 9 contributes to the lower CAR expression in NOD2 −/− CVB3 versus WT CVB3 mice. CVB3 replication relies on the autophagosome and subsequently induces its release via apoptosis. 3, 23 Because NOD2 induces autophagy and potentially interacts with the apoptotic pathway, 24 ablation of NOD2 may account for the impairment of these phenomena and subsequent reduction in viral load under CVB3 conditions. In agreement, cardiac apoptosis was reduced in NOD2 −/− CVB3 compared with WT CVB3, whereas in vitro examinations confirmed lower apoptosis in NOD2 siRNA CVB3 compared with CVB3 scr siRNA HL-1 cardiomyocytes, Figure 5 Continued. WT, n=4 for NOD2 −/− , n=5 for WT CVB3, and n=9 for NOD2 −/− CVB3 and *P<0.05. F, NOD2 mRNA expression in scr siRNA CVB3 and NOD2 siRNA CVB3-infected HL-1 cells compared with their respective controls 4 hours post infection. G-K, NLRP3 inflammasome activation, displayed as NLRP3 mRNA and ASC protein levels, caspase 1 activity, pro-IL-1β, and IL-1β protein levels in scr siRNA CVB3 and NOD2 siRNA CVB3-infected HL-1 cells versus respective controls 4 hours post infection. All data are reported as the mean±SEM with n=4 to 6 for scr siRNA, n=5 to 6 for NOD2 siRNA, n=5 to 6 for scr siRNA CVB3, and n=6 for NOD2 siRNA CVB3-infected HL-1 and *P<0.05, **P<0.005, and ***P<0.0005. NOD2 indicates nucleotide-binding oligomerization domain 2.
be it at a lesser extent compared with the in vivo conditions. This indicates that NOD2 −/− affects apoptosis in also other cells than cardiomyocytes. In parallel, the impact of NOD2 −/− on the viral titer was also more pronounced in the LVs as in the in vitro setting. This finding supports the link between apoptosis and viral propagation, on the one hand, and the involvement of other cells than cardiomyocytes in this effect, on the other hand. In fact, CVB3 infects besides cardiomyocytes also cells of the immune system, including CD4 + T cells and Mac-1 + macrophages, which contribute to viral persistence. 25 Given the importance of the cardiosplenic axis in CVB3-induced myocarditis, 26 −/− mice were accompanied with lower IFN-β production. IFN-β is not only critical for control of viral propagation but also potentiates the NOD1/NOD2 signaling pathway and, thus, harmful cytokines. 27 The direct antiviral effects of NOD2 −/− raise the question whether the decreased activity of the NLRP3 inflammasome and their related inflammatory effects are a direct consequence of the suppressed viral uptake, of a reduced NOD2-downstream signaling, and a consequence of both. The exact underlying mechanism needs further investigation. Nevertheless, findings of Wang et al 10 showing similar viral titers between CVB3 mice and CVB3 mice treated with an inhibitor of caspase 1, blocking inflammasome activity, characterized by lower IL-1β serum levels and improved LV function, suggest that an impact of the inflammasome on CAR is unlikely.
The less pronounced cardiac fibrosis in NOD2 −/− CVB3 versus WT CVB3 mice are in line with findings in a mouse model of myocardial infarction, whereby NOD2 ablation resulted in diminished TGF-β mRNA levels and less alpha-smooth muscle actin protein production and activity. 18 Because TGF-β is produced by infiltrating monocytes and T cells, which express NOD2, 28 these findings suggest that the impaired infiltration of monocytes and T cells in NOD2 −/− CVB3 mice underlie the lower expression of TGF-β, leading to less myofibroblasts and, thus, less collagen I and III in NOD2 −/− CVB3 versus WT CVB3 mice, further corroborating the link between cardiac inflammation and cardiac fibrosis. 29, 30 The impaired cardiac fibrosis as well as less pronounced expression of proinflammatory cytokines with, among others, direct negative inotrope effects found in In summary, we demonstrated that NOD2 is upregulated in cardiac CVB3-positive versus CVB3-negative AMC, DCMi, DCM, and control patients. NOD2 expression was increased in CVB3-positive patients but not in patients with a persistence of other cardiotropic viruses like the dsDNA virus human herpesvirus 6 or the ssDNA virus parvovirus B19. 31 This finding was independent of the grade and modus of inflammation or cardiac function/remodeling, indicating the importance of the NOD2 pathway during cardiac CVB3 infection. We suggest, therefore, that coinfection with human herpesvirus 6 or parvovirus B19 found in some CVB3-positive patients was irrelevant for our findings on NOD2 signaling. The potential clinical relevance of NOD2 further follows from the consistent pairwise drop of NOD2 mRNA expression between time point 1 and 2 in CVB3-positive patients who eliminated CVB3 and improved cardiac function over time, an effect that was only found with respect to IL-1β in 4 out of 6 patients. Further studies have to show whether the analysis of NOD2 in EMB could be useful as an additional differential diagnostic marker for CVB3-induced myocarditis under clinical conditions. The relevance of NOD2 in CVB3-induced myocarditis could next be assessed in NOD2 −/− mice, which were protected from the detrimental effects of CVB3. The latter is in agreement with the finding that patients with an elimination of CVB3 responded with an improvement in cardiac function over time. We conclude that NOD2 is a major mediator in the pathogenesis of CVB3-induced myocarditis.
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